Gender Female
Petra Struwe is the Site Director of the Celerion Bioanalytical Services facility in Zurich, Switzerland. She is responsible for all bioanalytical operations, focusing on the strategic and tactical management of the LC-MS/MS and Ligand Binding Services groups. In this role Dr Struwe has successfully grown these businesses and implemented a
range of new technologies to drive efficiency and increase throughput.
Dr. Struwe has over 15 years experience in bioanalysis, developing and validating a variety of assays with both small and large molecules. This expertise has provided an in-depth understanding of client challenges and enables her to effectively develop solutions that deliver results.
Under Dr. Struwe’s leadership, the bioanalytical laboratory in Zurich has one of the largest Ligand Binding Services facilities in the world with over 25 years experience. By investing in the right automation technology, the team has maximized throughput and regularly analysed up to 200,000 samples annually. Dr. Struwe is focused on exploring innovative technologies and most recently has led the efforts to implement Dried Blood Spots (DBS) for both small and large molecules.
Dr. Struwe previously held the roles of Site Director and Director of Chromatography with MDS Pharma Services. She has international experience having held roles with Solvay Pharmaceuticals in Hannover, Germany; Okayama University of Science, Japan; and Physikalisch-technische Bundesanstalt, Braunschweig, Germany.
Dr. Struwe holds a PhD and diploma in chemistry from TH University Karlsruhe, Germany. She is an active member of the European Bioanalytical Forum (EBF) for small molecules and also participates in the Global CRO Council (GCC) and Global Bioanalytical Consortium (GBC).
